P. Marchisio, S. Esposito, M.Picca, E. Baggi,

Slides:



Advertisements
Similar presentations
Otitis Media Lawrence Pike.
Advertisements

Acute Otitis Media Trials: Evolution of Guidance Janice Soreth, M.D. Division of Anti-Infective Drug Products January 30, 2001.
Idsurv data on Diphtheria Pneumonia. Diphtheria An illness characterised by laryngitis or pharyngitis or tonsillitis, and an adherent membrane of the.
OTITIS MEDIA.
Objectives Upon completion of the lecture, students should be able to:  Define middle ear infection  Know the classification of otitis media (OM). 
Definitions  Middle ear is the area between the tympanic membrane and the inner ear including the Eustachian tube.  Otitis media (OM) is inflammation.
Otitis Media: Clinical Practice Guidelines and Current Management
Babak Saedi Imam Khomeini Hospital
Ears! Mark Hambly.
Indication for Otitis Media FDA Vaccine and Related Biologicals Advisory Committee Meeting May 21, 2002 Pneumococcal 7-Valent Conjugate Vaccine (Diphtheria.
Design of Clinical Trials of Antibiotic Therapy for Acute Otitis Media
The Variations and Deviations in the Use of Tympanostomy Tubes for Children with Otitis Media Salomeh Keyhani MD MPH Lawrence C. Kleinman MD MPH Michael.
The diagnosis of acute otitis media Paola Marchisio Department of Pediatric and Maternal Sciences, University of Milan Fondazione IRCCS Ospedale Maggiore.
Ear Tubes. The Ear AOM vs. OME Acute Otitis Media –Pus behind TM –Acute infection –Multiple severe complicaitons Mastoiditis Meningitis Brain abscess.
Discussion Otitis media is an infection of the middle section of the ear, as compared to external otitis (also known as swimmer's ear), which is an infection.
Development of Antibiotics for Otitis Media: Past, Present, and Future Janice Soreth, M.D. Director Division of Anti-Infective Drug Products.
1 Acute Otitis Media. 2 Acute Otitis Media Clinical Evidence. Neill O, et al. Search date Jan 2006 Acute otitis media (AOM) is a common condition for.
Risk factors, pathophysiology and causative agents of acute otitis media This teaching presentation for the ISOM website has been prepared by Tal Marom,
FinOM Efficacy Trial of 7-Valent Pneumococcal Conjugate Vaccine Terhi Kilpi National Public Health Institute (KTL) Finland.
Definitions of Otitis Media
Giebink – FDA – 07/11/02 Design Issues in Antimicrobial Treatment Trials of AOM G. Scott Giebink, M.D. Professor of Pediatrics and Otolaryngology Director,
MIDDLE EAR INFECTIONS.
1 Otitis Media Results from the Kaiser Permanente Efficacy Trial Steven Black, MD, Henry Shinefield, MD and Bruce Fireman, MS Kaiser Permanente Vaccine.
Acute Otitis Media To treat or not to treat Gary Kroukamp.
AOM. Otitis Media  Otitis Media with effusion (OME)  Acute Otitis Media (AOM)  Recurrent AOM  Chronic Otitis Media/Chronic Otitis Media with effusion.
Acute Otitis Media: Lessons Learned Thomas Smith, M.D. Division of Anti-Infective Drug Products.
( Ear II ) Diseases of External Ear & Otitis media
"Epidemiological Features of Rotavirus Infection among children below 5 years old in Jordan, Rationale for Vaccine Introduction,2015" Kareman Juma`ah Al-Zain.
Upper Respiratory Tract Infections (URIs) Dr Simin Dashti-Khavidaki, Department of Pharmacotherapy, Tehran University of Medical Sciences.
Department of Otorhinolaryngology
PREVALENCE OF OSTEOMYELITIS IN HIV INFECTED PATIENTS. PRESENTERS: 1. MOHAMED M. NOORANY- MBChB V (MUSOM) 2. MUKOYA AQUINATA (Sr)- MBChB V (MUSOM) FACILITATORS:
APIC Chapter 13 Journal Club March 16, 2015 Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults NEJM – July 30, :5 Presented.
Drugs for the Ear. Anatomy of the Ear  The external ear  Auricle or pinna  External auditory canal (EAC)  The middle ear  Malleus, incus, and stapes.
Adenoiditis.
Burden of acute otitis media, recurrent otitis media and tympanostomy tube insertion in urban, minority children less than 7 years of age in Boston: Comparison.
Acute Mastoiditis in the Pneumococcal Conjugate Vaccines Era
OTITIS MEDIA Definition: inflammation of the middle ear
Reduction in sociodemographic disparities for otitis media hospitalisation rates in young children following introduction of pneumococcal conjugate vaccine.
Respiratory tract infections
SEVERITY OF PNEUMOCOCCAL VS
MASTOIDITIS.
The Infectious Aetiology of Otitis Media in Young Children
Acute otitis media (with adequate therapy) middle ear a viral upper
Dr. Ihsan E. Al-Saimary Ph. D. Assist Prof
Ear culture D. M. M. Lab..
Acute otitis Media And Otitis Media with Effusion By Prof
MICROBIOLOGY OF MIDDLE EAR INFECTION (OTITIS MEDIA)
ADEIGA.A, AWODERU O.A,FANEYE.A, AKINTUNDE, GB, ONYEWUCHE.J.
Microbiology of Middle Ear Infections
LECTURE: Microbiology of Middle Ear Infections
Otitis Externa.
Otitis Media.
Tympanic Membrane Perforation
Pneumococcal Disease Prevention in Children: Issues in the Era of PCVs
PCP: management of co-infection
درمان عفونت های شایع ENT
S. Skovbjerg, K. Roos, F. Nowrouzian, M. Lindh, S. E. Holm, I
Pneumococcal conjugate vaccines: overview of a decade from Kuwait
By: Anitha Jacob PA-S November 8, 2000
PCP: management of co-infection
Ear Culture بسم الله الرحمن الرحيم
Carriage of resistant pneumococci by children in southern Israel and impact of conjugate vaccines on carriage  Ron Dagan, Drora Fraser, Noga Givon, Pablo.
Clinical Microbiology and Infection
MICROBIOLOGY OF MIDDLE EAR INFECTION (OTITIS MEDIA)
Otitis Media Dr. Yasir Hakim, MD Pathology& Microbiology.
Acute Otitis Media in the 21st Century: What Now. Richard C
Ear Culture بسم الله الرحمن الرحيم
Meningitis Created By: VSU Student Health Center Nursing Staff
Presentation transcript:

P. Marchisio, S. Esposito, M.Picca, E. Baggi, PROSPECTIVE EVALUATION OF THE ETIOLOGY AND PATHOGENESIS OF ACUTE OTTIS MEDIA WITH SPONTANEOUS TYMPANIC MEMBRANE PERFORATION P. Marchisio, S. Esposito, M.Picca, E. Baggi, A. Orenti, E. Biganzoli, N. Principi Pediatric Highly Intensive Care Unit, Department of Pathophysiology and Transplantation, Fondazione IRCSS Cà Granda Ospedale Maggiore University of Milan, Milan, Italy

BACKGROUND Spontaneous tympanic membrane perforation (STMP) can occur during an episode of acute otitis media (AOM) and complicate the clinical course of the disease. Incidence of AOM with STMP varies between 5% and 30%. Several studies have suggested that AOM with STMP could have some specific characteristics and be differentiated from uncomplicated AOM.

OBJECTIVES To evaluate the microbiology of acute otitis media with otorrhea due to spontaneous tympanic membrane perforation in children living in Italy To evaluate pneumococcal serotypes

prospective, single-center study, Italy METHODS (1) prospective, single-center study, Italy enrollment for 12 months: May 1, 2015 to April 30, 2016 previously healthy children (6 m – 7 yrs) diagnosis of AOM with spontaneous otorrhea: (a) middle ear effusion + signs of acute inflammation of the tympanic membrane + acute symptoms and (b) otorrhea (within 12 hours of spontaneous rupture of TM)

METHODS (2) excluded: tubes, midfacial abnormalities, chronic middle ear conditions, including chronic perforation, immunodeficiency, antibiotics in the previous 2 weeks, topical treatment purulent fluid removed and MEE collected close to the perforation using an extra-thin flexible wire swab (Copan eNAT transport and preservation medium, Brescia, Italy). bacterial genomic DNA was extracted by clinical specimens by semi-automatic DNA extraction system. The presence of Streptococcus pneumoniae (S.pn) (and its serotypes) , Haemophilus influenzae (Hi), Moraxella catarrhalis (M.cat), group A beta hemolyticus Streptocccus (GABHS) and Staphylococcus aureus was evaluated by means of real-time PCR using specific oligos-probe sets. S.pn. cases were serotyped using primers and probes designed on the basis of the GenBank database sequences (www.ncbi.nlm.nih.gov)

STUDY POPULATION Children N = 177 (%) Sex (males) Age (group) < 2 years 2 - 4 years > 5 years mean age ± SD (years) History of rAOM PCV13 fully vaccinated 103 (58.2) 65 (36.7) 70 (39.6) 42 (23.7) 3.5 ± 2.7 100 (56.5) 162 (91.5)

PATHOGENS DETECTED ALONE OR AS CO-PATHOGENS Il patogeno identificato più frequentemente è risultato essere H. influenzae (90 campioni, 50,8% del totale), seguito da M. catarrhalis, S. pneumoniae, S. pyogenes e infine S. aureus. All H.influenzae strains were non typeable

How many children had a positive sample for one or more pathogens?

Non typeable H.Influenzae  the most frequent pathogen (70%) in co-infections (M.catarrhalis  GAS  S.pneumoniae)

COMPARISON BETWEEN TIME AND DETECTION METHODS Il patogeno identificato più frequentemente è risultato essere H. influenzae (90 campioni, 50,8% del totale), seguito da M. catarrhalis, S. pneumoniae, S. pyogenes e infine S. aureus. PCR – Italian data 2015 to 2016 Marchisio P et al., CMI, epub 2017 Culture – Italian data 2001 to 2011 Marchisio P et al., Infection, 2013

Streptococcus pneumoniae positive cases: age distribution

Streptococcus pneumoniae positive cases: PCV13 versus non-PCV13 serotypes

Streptococcus pneumoniae serotypes PCV7 PCV13 non PCV13

CONCLUSIONS - 1 Non typeable H.influenzae , which is the most frequently pathogen associated with biofilm formation, is predominant in spontaneous otorrhea Group A Strep is confirmed to be a main cause of otorrhea, especially in older children M. catharralis seems to be a relevant pathogen Co-infections are common , especially in children with recurrent AOM and especially for NTHi The therapeutic approach should be different from that which is usually reported for uncomplicated AOM, taking into account the possible formation of biolfim and the presence of betalactamase producers

CONCLUSIONS - 2 S. pneumoniae is still one of the main pathogens despite full immunization with PCV13 most of the pneumococcal cases are associated with serotypes not included in the vaccine. This finding suggests that a significant replacement phenomenon has developed, reducing the potential effect of PCV13 on AOM incidence periodical monitoring of pneumococcal ST circulation after introduction of PCV with a defined number of ST is needed in order to evaluate replacement phenomenon and the need for new vaccines with greater protective activity

Thank you for your attention